Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, especially those with ...
Jan 26, 2024
0
1
Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend active surveillance, which involves regular monitoring and thus avoids or delays treatment like surgery or radiation ...
Jan 22, 2024
0
0
The number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with ...
Apr 3, 2023
0
8
From 2014 to 2021, the rates of active surveillance for low-risk prostate cancer increased, but considerable practice- and practitioner-level variation is seen in its use, according to a study published online March 2 in ...
Mar 9, 2023
0
4
According to a new, nationwide study led by researchers at the American Cancer Society (ACS), millions of people in the United States continued to miss critical cancer screening tests during the second year of the COVID-19 ...
Feb 23, 2023
0
2
A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A. Anna Ioannidou of Imperial ...
Jan 27, 2022
0
59
For men with "low-risk" prostate cancer initially managed with active surveillance, cancer-related factors such as tumor grade and size are key risk factors for conversion to active treatment, reports a study in The Journal ...
Sep 10, 2021
0
3
Men over 60 with low-risk prostate cancer could spend ten years with no active treatment, have a better sex life as a result, yet still be very unlikely to die from the disease, new research has found.
Jul 12, 2021
0
1
Using the first results from an analysis of the world's largest active surveillance prostate cancer database, the GAP3 consortium has begun to identify which patients are at risk of developing the disease and which patients ...
Jul 20, 2020
0
8
(HealthDay)—National, race-based differences in prostate cancer survival are due to regional variation, even for low-risk prostate cancer, according to a study published online March 31 in JAMA Network Open.
Apr 13, 2020
0
1
